sözaltı news Science
Science
EN AZ

Clinical classification of multiple sclerosis by machine learning

nature.com 07.11.2026 01:00 8 views

Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system that affects many adults and causes substantial neurological disability. Its clinical presentations are highly heterogeneous, and distinguishing clinically isolated syndrome (CIS), relapsing-remitting MS and progressive subtypes remains difficult, even though subtype determines treatment. Machine learning offers a way to address this difficulty: it identifies subtle patterns in high-dimensional biomedical data and has shown promise for MS classification from neuroimaging, whereas its performance on transcriptomic data has received less attention.

To examine this question, we benchmarked three ensemble classifiers, AdaBoost, Random Forest and XGBoost, on 594 peripheral-blood mononuclear-cell transcriptomes from three public datasets, using a shared 6,033-gene matrix for four binary tasks: MS versus non-MS, CIS versus non-CIS, primary progressive versus relapsing-remitting MS, and secondary progressive versus relapsing-remitting MS. Models were evaluated on a 3:1 training/held-out split after standardization and two-component principal component analysis. All three classifiers achieved high held-out performance across the four tasks.

These results indicate that ensemble machine learning can effectively classify MS and its clinical subtypes from blood transcriptomic profiles. The authors thank all participating patients and healthy volunteers for their invaluable contributions. We would also like to acknowledge the GEO and ArrayExpress databases for providing access to raw transcriptomic data, as well as the developers of the machine learning libraries used in this study.

Finally, we appreciate the constructive feedback from reviewers and colleagues. Haibao Liu and Wenjie Li contributed equally to this work. Center for Rehabilitation Medicine, Department of Neurology, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China Department of Neurology, Longjiang First People’s Hospital, Qiqihar, Heilongjiang, China Southwest University of Political Science and Law, Chongqing, China The authors declare no competing interests.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Extract — continue reading at the source.

Read full story